Treatment for behavioral insomnia in young children with neurotypical development under 6 years of age: A systematic review
Résumé
This literature review examines all treatments for behavioral insomnia in children under 6 years of age to
determine which treatments have empirically demonstrated efficacy. Following PRISMA guidelines, three
databases were investigated (Pubmed, Cochrane and Psychinfo) to select randomized controlled trials (RCTs) which
assess treatments for behavioral insomnia in children under 6 years of age, all with neurotypical development. A
total of 908 articles met the search criteria. 21 articles were selected and analyzed in their entirety for a total of
2363 children (ranging from 2 months to 6 years of age). Based on these studies, treatment of behavioral
insomnia in young children under 6 years of age is primarily based on behavioral therapy. There is no evidence
that pharmacological treatments are effective in the long term for neurotypical children. This review highlights
the lack of RCTs in this field: new RCTs should be carried out among young children to refine and optimize the
therapeutic approach and to address the risk of therapeutic abuse through the use of non-scientifically validated
methods.
Fichier principal
1-s2.0-S1087079224000133-main.pdf (1.56 Mo)
Télécharger le fichier
1-s2.0-S1087079224000133-mmc1.pdf (242.26 Ko)
Télécharger le fichier
Origine | Fichiers éditeurs autorisés sur une archive ouverte |
---|---|
licence |
Origine | Fichiers produits par l'(les) auteur(s) |
---|---|
licence |